Research Sparks Innovation
Dementia is a progressive and debilitating disease that affects millions of people worldwide. Early diagnosis of Alzheimer’s disease (AD), the leading cause of dementia, is
Dementia is a progressive and debilitating disease that affects millions of people worldwide. Early diagnosis of Alzheimer’s disease (AD), the leading cause of dementia, is
By Björn Schelter Diagnosing dementia, or Alzheimer’s disease – its most common form – is a challenging and lengthy process. The current patient journey is
Patient appointments are a bottleneck in the diagnostic pathway of dementia. A diagnosis typically requires several visits, often to different specialists. In addition, only very
Free Virtual Event Annual Life Sciences Conference: Realising the Covid Legacy GT Diagnostics will be attending The Scotsman Annual Life Sciences Conference 2021 on December
GT Diagnostics and TauRx Therapeutics Ltd. will be presenting at the Alzheimer Europe Conference on Nov 29th – Dec 1st 2021. Our focus during the special symposium
GT Diagnostics were proud to have been part of the ADI Report 2021 Webinar Part 2: Innovations in diagnosis and diagnostics. Our very own Dr